Public Inspection: CMS: Medicare Program: Inflation Reduction Act of 2022 Medicare Drug Price Negotiation Program Draft Guidance
Source
Federal Register
Link
Date
Jul 17, 2026
Summary
Pre-publication notice from the Centers for Medicare &
Medicaid Services (CMS) seeking comments on draft guidance
for the Medicare Drug Price Negotiation Program regarding
manufacturer effectuation of the maximum fair price in 2028
for the implementation of the Inflation Reduction Act of
2022 (IRA). Comments are due within 60 days of the
publication of this notice, which is scheduled for July 20,
2026.
Tagged as
Healthcare business and finance
· Legislation and regulations
· Pharmacy and prescription drugs